nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—BCHE—multiple sclerosis	0.249	1	CbGaD
Cisplatin—GSTM1—Azathioprine—multiple sclerosis	0.162	0.319	CbGbCtD
Cisplatin—XDH—Azathioprine—multiple sclerosis	0.0671	0.133	CbGbCtD
Cisplatin—CYP4A11—Dexamethasone—multiple sclerosis	0.0437	0.0863	CbGbCtD
Cisplatin—SLC22A2—Cladribine—multiple sclerosis	0.0309	0.061	CbGbCtD
Cisplatin—BCHE—Triamcinolone—multiple sclerosis	0.0246	0.0485	CbGbCtD
Cisplatin—ABCG2—Cladribine—multiple sclerosis	0.0228	0.045	CbGbCtD
Cisplatin—PTGS2—Triamcinolone—multiple sclerosis	0.0189	0.0373	CbGbCtD
Cisplatin—ABCC3—Methotrexate—multiple sclerosis	0.0169	0.0333	CbGbCtD
Cisplatin—ABCG2—Mitoxantrone—multiple sclerosis	0.0166	0.0329	CbGbCtD
Cisplatin—PTGS2—Betamethasone—multiple sclerosis	0.0162	0.032	CbGbCtD
Cisplatin—ABCC2—Dexamethasone—multiple sclerosis	0.00954	0.0188	CbGbCtD
Cisplatin—PTGS2—Dexamethasone—multiple sclerosis	0.00943	0.0186	CbGbCtD
Cisplatin—ABCG2—Dexamethasone—multiple sclerosis	0.00862	0.017	CbGbCtD
Cisplatin—ABCB1—Methylprednisolone—multiple sclerosis	0.00822	0.0162	CbGbCtD
Cisplatin—ABCC2—Methotrexate—multiple sclerosis	0.00767	0.0151	CbGbCtD
Cisplatin—ABCG2—Methotrexate—multiple sclerosis	0.00693	0.0137	CbGbCtD
Cisplatin—CYP2B6—Dexamethasone—multiple sclerosis	0.00607	0.012	CbGbCtD
Cisplatin—ABCB1—Mitoxantrone—multiple sclerosis	0.006	0.0118	CbGbCtD
Cisplatin—ABCB1—Betamethasone—multiple sclerosis	0.00535	0.0106	CbGbCtD
Cisplatin—ABCB1—Prednisolone—multiple sclerosis	0.00528	0.0104	CbGbCtD
Cisplatin—ABCB1—Prednisone—multiple sclerosis	0.00498	0.00984	CbGbCtD
Cisplatin—CYP2C9—Dexamethasone—multiple sclerosis	0.0032	0.00633	CbGbCtD
Cisplatin—ABCB1—Dexamethasone—multiple sclerosis	0.00311	0.00614	CbGbCtD
Cisplatin—ABCB1—Methotrexate—multiple sclerosis	0.0025	0.00494	CbGbCtD
Cisplatin—PTGS2—leg—multiple sclerosis	0.00117	0.0287	CbGeAlD
Cisplatin—ABCC6—retina—multiple sclerosis	0.000996	0.0243	CbGeAlD
Cisplatin—SLC31A2—medulla oblongata—multiple sclerosis	0.000891	0.0218	CbGeAlD
Cisplatin—SLC31A2—midbrain—multiple sclerosis	0.000814	0.0199	CbGeAlD
Cisplatin—MT2A—spinal cord—multiple sclerosis	0.000808	0.0198	CbGeAlD
Cisplatin—SLC31A2—spinal cord—multiple sclerosis	0.000794	0.0194	CbGeAlD
Cisplatin—ATP7A—medulla oblongata—multiple sclerosis	0.000785	0.0192	CbGeAlD
Cisplatin—MT1A—cerebellum—multiple sclerosis	0.000769	0.0188	CbGeAlD
Cisplatin—ATP7B—nervous system—multiple sclerosis	0.000733	0.0179	CbGeAlD
Cisplatin—ATP7A—midbrain—multiple sclerosis	0.000717	0.0175	CbGeAlD
Cisplatin—ATP7B—central nervous system—multiple sclerosis	0.000705	0.0172	CbGeAlD
Cisplatin—ATP7A—spinal cord—multiple sclerosis	0.0007	0.0171	CbGeAlD
Cisplatin—ATP7B—cerebellum—multiple sclerosis	0.000689	0.0168	CbGeAlD
Cisplatin—SOD1—medulla oblongata—multiple sclerosis	0.000687	0.0168	CbGeAlD
Cisplatin—MT2A—nervous system—multiple sclerosis	0.000681	0.0166	CbGeAlD
Cisplatin—ABCC5—retina—multiple sclerosis	0.000677	0.0166	CbGeAlD
Cisplatin—SLC31A1—medulla oblongata—multiple sclerosis	0.00067	0.0164	CbGeAlD
Cisplatin—SLC31A2—nervous system—multiple sclerosis	0.000669	0.0164	CbGeAlD
Cisplatin—GSTT1—nervous system—multiple sclerosis	0.000667	0.0163	CbGeAlD
Cisplatin—MT2A—central nervous system—multiple sclerosis	0.000656	0.016	CbGeAlD
Cisplatin—SLC31A2—central nervous system—multiple sclerosis	0.000645	0.0157	CbGeAlD
Cisplatin—NQO1—retina—multiple sclerosis	0.000634	0.0155	CbGeAlD
Cisplatin—SLC31A2—cerebellum—multiple sclerosis	0.00063	0.0154	CbGeAlD
Cisplatin—SOD1—midbrain—multiple sclerosis	0.000628	0.0153	CbGeAlD
Cisplatin—MT1A—brain—multiple sclerosis	0.000625	0.0153	CbGeAlD
Cisplatin—SOD1—spinal cord—multiple sclerosis	0.000613	0.015	CbGeAlD
Cisplatin—SLC31A1—midbrain—multiple sclerosis	0.000612	0.015	CbGeAlD
Cisplatin—SLC31A1—spinal cord—multiple sclerosis	0.000597	0.0146	CbGeAlD
Cisplatin—GSTP1—retina—multiple sclerosis	0.000566	0.0138	CbGeAlD
Cisplatin—ATP7B—brain—multiple sclerosis	0.00056	0.0137	CbGeAlD
Cisplatin—MT2A—brain—multiple sclerosis	0.000521	0.0127	CbGeAlD
Cisplatin—SLC31A2—brain—multiple sclerosis	0.000512	0.0125	CbGeAlD
Cisplatin—SLC31A1—nervous system—multiple sclerosis	0.000503	0.0123	CbGeAlD
Cisplatin—GSTM1—nervous system—multiple sclerosis	0.000491	0.012	CbGeAlD
Cisplatin—ABCC5—medulla oblongata—multiple sclerosis	0.00049	0.012	CbGeAlD
Cisplatin—SOD1—cerebellum—multiple sclerosis	0.000486	0.0119	CbGeAlD
Cisplatin—SLC31A1—central nervous system—multiple sclerosis	0.000484	0.0118	CbGeAlD
Cisplatin—SLC31A1—cerebellum—multiple sclerosis	0.000473	0.0116	CbGeAlD
Cisplatin—GSTM1—central nervous system—multiple sclerosis	0.000473	0.0116	CbGeAlD
Cisplatin—GSTM1—cerebellum—multiple sclerosis	0.000462	0.0113	CbGeAlD
Cisplatin—NQO1—medulla oblongata—multiple sclerosis	0.000458	0.0112	CbGeAlD
Cisplatin—ATP7A—brain—multiple sclerosis	0.000451	0.011	CbGeAlD
Cisplatin—ABCC5—midbrain—multiple sclerosis	0.000447	0.0109	CbGeAlD
Cisplatin—NQO1—midbrain—multiple sclerosis	0.000419	0.0102	CbGeAlD
Cisplatin—GSTP1—medulla oblongata—multiple sclerosis	0.000409	0.01	CbGeAlD
Cisplatin—NQO1—spinal cord—multiple sclerosis	0.000408	0.00998	CbGeAlD
Cisplatin—SOD1—brain—multiple sclerosis	0.000395	0.00964	CbGeAlD
Cisplatin—SLC31A1—brain—multiple sclerosis	0.000385	0.0094	CbGeAlD
Cisplatin—MPO—spinal cord—multiple sclerosis	0.000376	0.00918	CbGeAlD
Cisplatin—GSTM1—brain—multiple sclerosis	0.000375	0.00917	CbGeAlD
Cisplatin—GSTP1—midbrain—multiple sclerosis	0.000374	0.00914	CbGeAlD
Cisplatin—GSTP1—spinal cord—multiple sclerosis	0.000365	0.00892	CbGeAlD
Cisplatin—BCHE—brainstem—multiple sclerosis	0.000355	0.00868	CbGeAlD
Cisplatin—ABCC5—cerebellum—multiple sclerosis	0.000346	0.00846	CbGeAlD
Cisplatin—NQO1—nervous system—multiple sclerosis	0.000344	0.00841	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000336	0.159	CbGdCrCtD
Cisplatin—NQO1—central nervous system—multiple sclerosis	0.000331	0.0081	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000331	0.156	CbGdCrCtD
Cisplatin—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000331	0.156	CbGdCrCtD
Cisplatin—NQO1—cerebellum—multiple sclerosis	0.000324	0.00791	CbGeAlD
Cisplatin—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000323	0.153	CbGdCrCtD
Cisplatin—MPO—nervous system—multiple sclerosis	0.000316	0.00773	CbGeAlD
Cisplatin—ABCC3—nervous system—multiple sclerosis	0.000309	0.00755	CbGeAlD
Cisplatin—GSTP1—nervous system—multiple sclerosis	0.000308	0.00752	CbGeAlD
Cisplatin—MPO—central nervous system—multiple sclerosis	0.000305	0.00744	CbGeAlD
Cisplatin—ABCC3—central nervous system—multiple sclerosis	0.000297	0.00727	CbGeAlD
Cisplatin—GSTP1—central nervous system—multiple sclerosis	0.000296	0.00724	CbGeAlD
Cisplatin—GSTP1—cerebellum—multiple sclerosis	0.000289	0.00707	CbGeAlD
Cisplatin—ABCC5—brain—multiple sclerosis	0.000281	0.00687	CbGeAlD
Cisplatin—NQO1—brain—multiple sclerosis	0.000263	0.00643	CbGeAlD
Cisplatin—BCHE—medulla oblongata—multiple sclerosis	0.000248	0.00606	CbGeAlD
Cisplatin—MPO—brain—multiple sclerosis	0.000242	0.00591	CbGeAlD
Cisplatin—ABCG2—medulla oblongata—multiple sclerosis	0.00024	0.00585	CbGeAlD
Cisplatin—ABCC3—brain—multiple sclerosis	0.000236	0.00577	CbGeAlD
Cisplatin—GSTP1—brain—multiple sclerosis	0.000235	0.00574	CbGeAlD
Cisplatin—BCHE—midbrain—multiple sclerosis	0.000227	0.00554	CbGeAlD
Cisplatin—BCHE—spinal cord—multiple sclerosis	0.000221	0.0054	CbGeAlD
Cisplatin—ABCG2—midbrain—multiple sclerosis	0.000219	0.00535	CbGeAlD
Cisplatin—ABCG2—spinal cord—multiple sclerosis	0.000214	0.00522	CbGeAlD
Cisplatin—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000203	0.0958	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.0002	0.0943	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.0002	0.0943	CbGdCrCtD
Cisplatin—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000195	0.0921	CbGdCrCtD
Cisplatin—PTGS2—medulla oblongata—multiple sclerosis	0.000191	0.00467	CbGeAlD
Cisplatin—BCHE—nervous system—multiple sclerosis	0.000186	0.00455	CbGeAlD
Cisplatin—BCHE—central nervous system—multiple sclerosis	0.000179	0.00438	CbGeAlD
Cisplatin—BCHE—cerebellum—multiple sclerosis	0.000175	0.00428	CbGeAlD
Cisplatin—PTGS2—midbrain—multiple sclerosis	0.000175	0.00426	CbGeAlD
Cisplatin—PTGS2—spinal cord—multiple sclerosis	0.00017	0.00416	CbGeAlD
Cisplatin—ABCG2—cerebellum—multiple sclerosis	0.000169	0.00414	CbGeAlD
Cisplatin—CYP2B6—nervous system—multiple sclerosis	0.000166	0.00406	CbGeAlD
Cisplatin—ABCB1—retina—multiple sclerosis	0.000163	0.00399	CbGeAlD
Cisplatin—CYP2B6—central nervous system—multiple sclerosis	0.00016	0.00391	CbGeAlD
Cisplatin—PTGS2—nervous system—multiple sclerosis	0.000143	0.00351	CbGeAlD
Cisplatin—BCHE—brain—multiple sclerosis	0.000142	0.00348	CbGeAlD
Cisplatin—PTGS2—central nervous system—multiple sclerosis	0.000138	0.00338	CbGeAlD
Cisplatin—ABCG2—brain—multiple sclerosis	0.000138	0.00336	CbGeAlD
Cisplatin—PTGS2—cerebellum—multiple sclerosis	0.000135	0.0033	CbGeAlD
Cisplatin—CYP2B6—brain—multiple sclerosis	0.000127	0.0031	CbGeAlD
Cisplatin—ABCB1—medulla oblongata—multiple sclerosis	0.000118	0.00289	CbGeAlD
Cisplatin—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000112	0.000957	CcSEcCtD
Cisplatin—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000112	0.000955	CcSEcCtD
Cisplatin—Anorexia—Mitoxantrone—multiple sclerosis	0.000112	0.000953	CcSEcCtD
Cisplatin—Arrhythmia—Triamcinolone—multiple sclerosis	0.000111	0.000949	CcSEcCtD
Cisplatin—Vision blurred—Prednisolone—multiple sclerosis	0.000111	0.000948	CcSEcCtD
Cisplatin—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000111	0.000947	CcSEcCtD
Cisplatin—Hypotension—Mitoxantrone—multiple sclerosis	0.00011	0.000935	CcSEcCtD
Cisplatin—PTGS2—brain—multiple sclerosis	0.00011	0.00268	CbGeAlD
Cisplatin—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000109	0.000933	CcSEcCtD
Cisplatin—Visual impairment—Dexamethasone—multiple sclerosis	0.000109	0.000929	CcSEcCtD
Cisplatin—Visual impairment—Betamethasone—multiple sclerosis	0.000109	0.000929	CcSEcCtD
Cisplatin—Erythema—Triamcinolone—multiple sclerosis	0.000109	0.000925	CcSEcCtD
Cisplatin—Erythema—Methylprednisolone—multiple sclerosis	0.000108	0.000923	CcSEcCtD
Cisplatin—Malnutrition—Methylprednisolone—multiple sclerosis	0.000108	0.000923	CcSEcCtD
Cisplatin—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000108	0.000922	CcSEcCtD
Cisplatin—ABCB1—midbrain—multiple sclerosis	0.000108	0.00264	CbGeAlD
Cisplatin—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000108	0.000916	CcSEcCtD
Cisplatin—Myocardial infarction—Prednisone—multiple sclerosis	0.000108	0.000916	CcSEcCtD
Cisplatin—Breast disorder—Methotrexate—multiple sclerosis	0.000108	0.000916	CcSEcCtD
Cisplatin—Hypersensitivity—Azathioprine—multiple sclerosis	0.000107	0.000912	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000107	0.000911	CcSEcCtD
Cisplatin—Malaise—Prednisolone—multiple sclerosis	0.000106	0.000907	CcSEcCtD
Cisplatin—Nausea—Cladribine—multiple sclerosis	0.000106	0.000904	CcSEcCtD
Cisplatin—Eye disorder—Betamethasone—multiple sclerosis	0.000106	0.000901	CcSEcCtD
Cisplatin—Eye disorder—Dexamethasone—multiple sclerosis	0.000106	0.000901	CcSEcCtD
Cisplatin—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000105	0.000898	CcSEcCtD
Cisplatin—ABCB1—spinal cord—multiple sclerosis	0.000105	0.00257	CbGeAlD
Cisplatin—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000105	0.000892	CcSEcCtD
Cisplatin—Convulsion—Prednisolone—multiple sclerosis	0.000102	0.000871	CcSEcCtD
Cisplatin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000102	0.000869	CcSEcCtD
Cisplatin—Arrhythmia—Dexamethasone—multiple sclerosis	0.000101	0.000861	CcSEcCtD
Cisplatin—Arrhythmia—Betamethasone—multiple sclerosis	0.000101	0.000861	CcSEcCtD
Cisplatin—Pancreatitis—Methotrexate—multiple sclerosis	0.000101	0.000859	CcSEcCtD
Cisplatin—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000101	0.000858	CcSEcCtD
Cisplatin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.0001	0.000856	CcSEcCtD
Cisplatin—Pain—Mitoxantrone—multiple sclerosis	0.0001	0.000855	CcSEcCtD
Cisplatin—Bradycardia—Prednisone—multiple sclerosis	0.0001	0.000854	CcSEcCtD
Cisplatin—Alopecia—Dexamethasone—multiple sclerosis	9.99e-05	0.000852	CcSEcCtD
Cisplatin—Alopecia—Betamethasone—multiple sclerosis	9.99e-05	0.000852	CcSEcCtD
Cisplatin—Diarrhoea—Azathioprine—multiple sclerosis	9.94e-05	0.000847	CcSEcCtD
Cisplatin—Discomfort—Prednisolone—multiple sclerosis	9.93e-05	0.000846	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—multiple sclerosis	9.86e-05	0.00084	CcSEcCtD
Cisplatin—Erythema—Dexamethasone—multiple sclerosis	9.85e-05	0.000839	CcSEcCtD
Cisplatin—Erythema—Betamethasone—multiple sclerosis	9.85e-05	0.000839	CcSEcCtD
Cisplatin—Malaise—Triamcinolone—multiple sclerosis	9.79e-05	0.000834	CcSEcCtD
Cisplatin—Pancytopenia—Methotrexate—multiple sclerosis	9.77e-05	0.000832	CcSEcCtD
Cisplatin—Malaise—Methylprednisolone—multiple sclerosis	9.76e-05	0.000832	CcSEcCtD
Cisplatin—Connective tissue disorder—Prednisone—multiple sclerosis	9.68e-05	0.000825	CcSEcCtD
Cisplatin—Feeling abnormal—Mitoxantrone—multiple sclerosis	9.67e-05	0.000824	CcSEcCtD
Cisplatin—Oedema—Prednisolone—multiple sclerosis	9.63e-05	0.000821	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisolone—multiple sclerosis	9.63e-05	0.000821	CcSEcCtD
Cisplatin—Convulsion—Triamcinolone—multiple sclerosis	9.4e-05	0.000801	CcSEcCtD
Cisplatin—Tachycardia—Prednisolone—multiple sclerosis	9.4e-05	0.000801	CcSEcCtD
Cisplatin—Convulsion—Methylprednisolone—multiple sclerosis	9.38e-05	0.000799	CcSEcCtD
Cisplatin—Hyperhidrosis—Prednisolone—multiple sclerosis	9.31e-05	0.000793	CcSEcCtD
Cisplatin—Body temperature increased—Mitoxantrone—multiple sclerosis	9.28e-05	0.000791	CcSEcCtD
Cisplatin—Myalgia—Triamcinolone—multiple sclerosis	9.24e-05	0.000787	CcSEcCtD
Cisplatin—Vomiting—Azathioprine—multiple sclerosis	9.23e-05	0.000787	CcSEcCtD
Cisplatin—Myalgia—Methylprednisolone—multiple sclerosis	9.22e-05	0.000785	CcSEcCtD
Cisplatin—Eye disorder—Prednisone—multiple sclerosis	9.21e-05	0.000784	CcSEcCtD
Cisplatin—Anxiety—Methylprednisolone—multiple sclerosis	9.19e-05	0.000783	CcSEcCtD
Cisplatin—Rash—Azathioprine—multiple sclerosis	9.16e-05	0.00078	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	9.15e-05	0.00078	CcSEcCtD
Cisplatin—Dermatitis—Azathioprine—multiple sclerosis	9.15e-05	0.000779	CcSEcCtD
Cisplatin—Flushing—Prednisone—multiple sclerosis	9.14e-05	0.000779	CcSEcCtD
Cisplatin—Ill-defined disorder—Dexamethasone—multiple sclerosis	9.14e-05	0.000778	CcSEcCtD
Cisplatin—Ill-defined disorder—Betamethasone—multiple sclerosis	9.14e-05	0.000778	CcSEcCtD
Cisplatin—Discomfort—Triamcinolone—multiple sclerosis	9.13e-05	0.000778	CcSEcCtD
Cisplatin—Discomfort—Methylprednisolone—multiple sclerosis	9.11e-05	0.000776	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—multiple sclerosis	9.01e-05	0.000768	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—multiple sclerosis	8.94e-05	0.000762	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—multiple sclerosis	8.91e-05	0.000759	CcSEcCtD
Cisplatin—Immune system disorder—Prednisone—multiple sclerosis	8.9e-05	0.000758	CcSEcCtD
Cisplatin—Malaise—Dexamethasone—multiple sclerosis	8.88e-05	0.000757	CcSEcCtD
Cisplatin—Malaise—Betamethasone—multiple sclerosis	8.88e-05	0.000757	CcSEcCtD
Cisplatin—ABCB1—nervous system—multiple sclerosis	8.87e-05	0.00217	CbGeAlD
Cisplatin—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.86e-05	0.000755	CcSEcCtD
Cisplatin—Oedema—Triamcinolone—multiple sclerosis	8.86e-05	0.000755	CcSEcCtD
Cisplatin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.84e-05	0.000753	CcSEcCtD
Cisplatin—Arrhythmia—Prednisone—multiple sclerosis	8.8e-05	0.00075	CcSEcCtD
Cisplatin—Infection—Triamcinolone—multiple sclerosis	8.8e-05	0.00075	CcSEcCtD
Cisplatin—Infection—Methylprednisolone—multiple sclerosis	8.78e-05	0.000748	CcSEcCtD
Cisplatin—Alopecia—Prednisone—multiple sclerosis	8.7e-05	0.000742	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—multiple sclerosis	8.67e-05	0.000739	CcSEcCtD
Cisplatin—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.67e-05	0.000738	CcSEcCtD
Cisplatin—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.65e-05	0.000737	CcSEcCtD
Cisplatin—Paraesthesia—Prednisolone—multiple sclerosis	8.65e-05	0.000737	CcSEcCtD
Cisplatin—Tachycardia—Triamcinolone—multiple sclerosis	8.64e-05	0.000736	CcSEcCtD
Cisplatin—Nausea—Azathioprine—multiple sclerosis	8.63e-05	0.000735	CcSEcCtD
Cisplatin—Tachycardia—Methylprednisolone—multiple sclerosis	8.62e-05	0.000735	CcSEcCtD
Cisplatin—Skin disorder—Methylprednisolone—multiple sclerosis	8.58e-05	0.000731	CcSEcCtD
Cisplatin—Erythema—Prednisone—multiple sclerosis	8.57e-05	0.000731	CcSEcCtD
Cisplatin—Malnutrition—Prednisone—multiple sclerosis	8.57e-05	0.000731	CcSEcCtD
Cisplatin—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.56e-05	0.00073	CcSEcCtD
Cisplatin—ABCB1—central nervous system—multiple sclerosis	8.54e-05	0.00209	CbGeAlD
Cisplatin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.54e-05	0.000728	CcSEcCtD
Cisplatin—Convulsion—Dexamethasone—multiple sclerosis	8.53e-05	0.000727	CcSEcCtD
Cisplatin—Convulsion—Betamethasone—multiple sclerosis	8.53e-05	0.000727	CcSEcCtD
Cisplatin—Asthenia—Mitoxantrone—multiple sclerosis	8.42e-05	0.000718	CcSEcCtD
Cisplatin—Myalgia—Dexamethasone—multiple sclerosis	8.38e-05	0.000714	CcSEcCtD
Cisplatin—Myalgia—Betamethasone—multiple sclerosis	8.38e-05	0.000714	CcSEcCtD
Cisplatin—Anxiety—Dexamethasone—multiple sclerosis	8.35e-05	0.000712	CcSEcCtD
Cisplatin—Anxiety—Betamethasone—multiple sclerosis	8.35e-05	0.000712	CcSEcCtD
Cisplatin—ABCB1—cerebellum—multiple sclerosis	8.35e-05	0.00204	CbGeAlD
Cisplatin—Discomfort—Dexamethasone—multiple sclerosis	8.28e-05	0.000706	CcSEcCtD
Cisplatin—Discomfort—Betamethasone—multiple sclerosis	8.28e-05	0.000706	CcSEcCtD
Cisplatin—Hypotension—Methylprednisolone—multiple sclerosis	8.26e-05	0.000704	CcSEcCtD
Cisplatin—Pain—Prednisolone—multiple sclerosis	8.24e-05	0.000702	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—multiple sclerosis	8.13e-05	0.000693	CcSEcCtD
Cisplatin—Vision blurred—Prednisone—multiple sclerosis	8.08e-05	0.000689	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—multiple sclerosis	8.07e-05	0.000688	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	8.07e-05	0.000688	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	8.05e-05	0.000686	CcSEcCtD
Cisplatin—Oedema—Betamethasone—multiple sclerosis	8.04e-05	0.000685	CcSEcCtD
Cisplatin—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.04e-05	0.000685	CcSEcCtD
Cisplatin—Oedema—Dexamethasone—multiple sclerosis	8.04e-05	0.000685	CcSEcCtD
Cisplatin—Anaphylactic shock—Betamethasone—multiple sclerosis	8.04e-05	0.000685	CcSEcCtD
Cisplatin—Diarrhoea—Mitoxantrone—multiple sclerosis	8.03e-05	0.000684	CcSEcCtD
Cisplatin—Infection—Dexamethasone—multiple sclerosis	7.98e-05	0.00068	CcSEcCtD
Cisplatin—Infection—Betamethasone—multiple sclerosis	7.98e-05	0.00068	CcSEcCtD
Cisplatin—Ill-defined disorder—Prednisone—multiple sclerosis	7.96e-05	0.000678	CcSEcCtD
Cisplatin—Paraesthesia—Triamcinolone—multiple sclerosis	7.95e-05	0.000678	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisolone—multiple sclerosis	7.94e-05	0.000676	CcSEcCtD
Cisplatin—Paraesthesia—Methylprednisolone—multiple sclerosis	7.93e-05	0.000676	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—multiple sclerosis	7.93e-05	0.000676	CcSEcCtD
Cisplatin—Anaemia—Prednisone—multiple sclerosis	7.93e-05	0.000675	CcSEcCtD
Cisplatin—Dyspnoea—Triamcinolone—multiple sclerosis	7.9e-05	0.000673	CcSEcCtD
Cisplatin—Nervous system disorder—Dexamethasone—multiple sclerosis	7.88e-05	0.000671	CcSEcCtD
Cisplatin—Nervous system disorder—Betamethasone—multiple sclerosis	7.88e-05	0.000671	CcSEcCtD
Cisplatin—Thrombocytopenia—Betamethasone—multiple sclerosis	7.87e-05	0.00067	CcSEcCtD
Cisplatin—Thrombocytopenia—Dexamethasone—multiple sclerosis	7.87e-05	0.00067	CcSEcCtD
Cisplatin—Tachycardia—Dexamethasone—multiple sclerosis	7.84e-05	0.000668	CcSEcCtD
Cisplatin—Tachycardia—Betamethasone—multiple sclerosis	7.84e-05	0.000668	CcSEcCtD
Cisplatin—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.77e-05	0.000662	CcSEcCtD
Cisplatin—Hyperhidrosis—Betamethasone—multiple sclerosis	7.77e-05	0.000662	CcSEcCtD
Cisplatin—Malaise—Prednisone—multiple sclerosis	7.73e-05	0.000659	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—multiple sclerosis	7.69e-05	0.000656	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—multiple sclerosis	7.68e-05	0.000654	CcSEcCtD
Cisplatin—Anorexia—Betamethasone—multiple sclerosis	7.66e-05	0.000653	CcSEcCtD
Cisplatin—Anorexia—Dexamethasone—multiple sclerosis	7.66e-05	0.000653	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—multiple sclerosis	7.64e-05	0.000651	CcSEcCtD
Cisplatin—Pain—Triamcinolone—multiple sclerosis	7.57e-05	0.000645	CcSEcCtD
Cisplatin—Hypotension—Betamethasone—multiple sclerosis	7.51e-05	0.00064	CcSEcCtD
Cisplatin—Hypotension—Dexamethasone—multiple sclerosis	7.51e-05	0.00064	CcSEcCtD
Cisplatin—Vomiting—Mitoxantrone—multiple sclerosis	7.46e-05	0.000636	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—multiple sclerosis	7.44e-05	0.000634	CcSEcCtD
Cisplatin—Convulsion—Prednisone—multiple sclerosis	7.43e-05	0.000633	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—multiple sclerosis	7.42e-05	0.000632	CcSEcCtD
Cisplatin—Rash—Mitoxantrone—multiple sclerosis	7.4e-05	0.000631	CcSEcCtD
Cisplatin—Dermatitis—Mitoxantrone—multiple sclerosis	7.39e-05	0.00063	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.32e-05	0.000624	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.32e-05	0.000624	CcSEcCtD
Cisplatin—Myalgia—Prednisone—multiple sclerosis	7.3e-05	0.000622	CcSEcCtD
Cisplatin—Feeling abnormal—Triamcinolone—multiple sclerosis	7.3e-05	0.000622	CcSEcCtD
Cisplatin—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.28e-05	0.00062	CcSEcCtD
Cisplatin—Anxiety—Prednisone—multiple sclerosis	7.27e-05	0.00062	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—multiple sclerosis	7.27e-05	0.00062	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.25e-05	0.000618	CcSEcCtD
Cisplatin—Paraesthesia—Dexamethasone—multiple sclerosis	7.22e-05	0.000615	CcSEcCtD
Cisplatin—Paraesthesia—Betamethasone—multiple sclerosis	7.22e-05	0.000615	CcSEcCtD
Cisplatin—Discomfort—Prednisone—multiple sclerosis	7.21e-05	0.000615	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—multiple sclerosis	7.17e-05	0.000611	CcSEcCtD
Cisplatin—Erythema—Methotrexate—multiple sclerosis	7.17e-05	0.000611	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisolone—multiple sclerosis	7.1e-05	0.000605	CcSEcCtD
Cisplatin—Body temperature increased—Triamcinolone—multiple sclerosis	7e-05	0.000597	CcSEcCtD
Cisplatin—Oedema—Prednisone—multiple sclerosis	7e-05	0.000596	CcSEcCtD
Cisplatin—Anaphylactic shock—Prednisone—multiple sclerosis	7e-05	0.000596	CcSEcCtD
Cisplatin—Decreased appetite—Dexamethasone—multiple sclerosis	6.99e-05	0.000595	CcSEcCtD
Cisplatin—Decreased appetite—Betamethasone—multiple sclerosis	6.99e-05	0.000595	CcSEcCtD
Cisplatin—Nausea—Mitoxantrone—multiple sclerosis	6.97e-05	0.000594	CcSEcCtD
Cisplatin—Infection—Prednisone—multiple sclerosis	6.95e-05	0.000592	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.94e-05	0.000591	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.94e-05	0.000591	CcSEcCtD
Cisplatin—Pain—Dexamethasone—multiple sclerosis	6.87e-05	0.000586	CcSEcCtD
Cisplatin—Pain—Betamethasone—multiple sclerosis	6.87e-05	0.000586	CcSEcCtD
Cisplatin—Nervous system disorder—Prednisone—multiple sclerosis	6.86e-05	0.000585	CcSEcCtD
Cisplatin—Tachycardia—Prednisone—multiple sclerosis	6.83e-05	0.000582	CcSEcCtD
Cisplatin—Skin disorder—Prednisone—multiple sclerosis	6.8e-05	0.000579	CcSEcCtD
Cisplatin—ABCB1—brain—multiple sclerosis	6.78e-05	0.00166	CbGeAlD
Cisplatin—Hyperhidrosis—Prednisone—multiple sclerosis	6.77e-05	0.000576	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—multiple sclerosis	6.75e-05	0.000575	CcSEcCtD
Cisplatin—Anorexia—Prednisone—multiple sclerosis	6.67e-05	0.000568	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—multiple sclerosis	6.65e-05	0.000567	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—multiple sclerosis	6.62e-05	0.000564	CcSEcCtD
Cisplatin—Feeling abnormal—Betamethasone—multiple sclerosis	6.62e-05	0.000564	CcSEcCtD
Cisplatin—Feeling abnormal—Dexamethasone—multiple sclerosis	6.62e-05	0.000564	CcSEcCtD
Cisplatin—Hypersensitivity—Triamcinolone—multiple sclerosis	6.52e-05	0.000556	CcSEcCtD
Cisplatin—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.51e-05	0.000555	CcSEcCtD
Cisplatin—Malaise—Methotrexate—multiple sclerosis	6.46e-05	0.000551	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—multiple sclerosis	6.41e-05	0.000547	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.38e-05	0.000543	CcSEcCtD
Cisplatin—Asthenia—Triamcinolone—multiple sclerosis	6.35e-05	0.000541	CcSEcCtD
Cisplatin—Body temperature increased—Betamethasone—multiple sclerosis	6.35e-05	0.000541	CcSEcCtD
Cisplatin—Body temperature increased—Dexamethasone—multiple sclerosis	6.35e-05	0.000541	CcSEcCtD
Cisplatin—Asthenia—Methylprednisolone—multiple sclerosis	6.34e-05	0.00054	CcSEcCtD
Cisplatin—Paraesthesia—Prednisone—multiple sclerosis	6.28e-05	0.000535	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—multiple sclerosis	6.21e-05	0.000529	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—multiple sclerosis	6.1e-05	0.00052	CcSEcCtD
Cisplatin—Decreased appetite—Prednisone—multiple sclerosis	6.08e-05	0.000518	CcSEcCtD
Cisplatin—Rash—Prednisolone—multiple sclerosis	6.07e-05	0.000517	CcSEcCtD
Cisplatin—Dermatitis—Prednisolone—multiple sclerosis	6.07e-05	0.000517	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.06e-05	0.000516	CcSEcCtD
Cisplatin—Diarrhoea—Methylprednisolone—multiple sclerosis	6.05e-05	0.000515	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—multiple sclerosis	6.03e-05	0.000514	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—multiple sclerosis	5.85e-05	0.000498	CcSEcCtD
Cisplatin—Infection—Methotrexate—multiple sclerosis	5.81e-05	0.000495	CcSEcCtD
Cisplatin—Feeling abnormal—Prednisone—multiple sclerosis	5.77e-05	0.000491	CcSEcCtD
Cisplatin—Asthenia—Dexamethasone—multiple sclerosis	5.77e-05	0.000491	CcSEcCtD
Cisplatin—Asthenia—Betamethasone—multiple sclerosis	5.77e-05	0.000491	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—multiple sclerosis	5.74e-05	0.000489	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—multiple sclerosis	5.73e-05	0.000488	CcSEcCtD
Cisplatin—Nausea—Prednisolone—multiple sclerosis	5.72e-05	0.000487	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—multiple sclerosis	5.68e-05	0.000484	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—multiple sclerosis	5.65e-05	0.000482	CcSEcCtD
Cisplatin—Vomiting—Triamcinolone—multiple sclerosis	5.63e-05	0.00048	CcSEcCtD
Cisplatin—Vomiting—Methylprednisolone—multiple sclerosis	5.62e-05	0.000479	CcSEcCtD
Cisplatin—Rash—Triamcinolone—multiple sclerosis	5.58e-05	0.000476	CcSEcCtD
Cisplatin—Dermatitis—Triamcinolone—multiple sclerosis	5.58e-05	0.000475	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—multiple sclerosis	5.57e-05	0.000475	CcSEcCtD
Cisplatin—Rash—Methylprednisolone—multiple sclerosis	5.57e-05	0.000475	CcSEcCtD
Cisplatin—Dermatitis—Methylprednisolone—multiple sclerosis	5.57e-05	0.000474	CcSEcCtD
Cisplatin—Body temperature increased—Prednisone—multiple sclerosis	5.53e-05	0.000471	CcSEcCtD
Cisplatin—Diarrhoea—Dexamethasone—multiple sclerosis	5.5e-05	0.000468	CcSEcCtD
Cisplatin—Diarrhoea—Betamethasone—multiple sclerosis	5.5e-05	0.000468	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—multiple sclerosis	5.47e-05	0.000466	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.33e-05	0.000454	CcSEcCtD
Cisplatin—Nausea—Triamcinolone—multiple sclerosis	5.26e-05	0.000448	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—multiple sclerosis	5.25e-05	0.000447	CcSEcCtD
Cisplatin—Nausea—Methylprednisolone—multiple sclerosis	5.25e-05	0.000447	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—multiple sclerosis	5.21e-05	0.000444	CcSEcCtD
Cisplatin—Hypersensitivity—Prednisone—multiple sclerosis	5.16e-05	0.000439	CcSEcCtD
Cisplatin—Vomiting—Dexamethasone—multiple sclerosis	5.11e-05	0.000435	CcSEcCtD
Cisplatin—Vomiting—Betamethasone—multiple sclerosis	5.11e-05	0.000435	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—multiple sclerosis	5.08e-05	0.000433	CcSEcCtD
Cisplatin—Rash—Dexamethasone—multiple sclerosis	5.07e-05	0.000432	CcSEcCtD
Cisplatin—Rash—Betamethasone—multiple sclerosis	5.07e-05	0.000432	CcSEcCtD
Cisplatin—Dermatitis—Dexamethasone—multiple sclerosis	5.06e-05	0.000431	CcSEcCtD
Cisplatin—Dermatitis—Betamethasone—multiple sclerosis	5.06e-05	0.000431	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.05e-05	0.00043	CcSEcCtD
Cisplatin—Asthenia—Prednisone—multiple sclerosis	5.02e-05	0.000428	CcSEcCtD
Cisplatin—Pain—Methotrexate—multiple sclerosis	5e-05	0.000426	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—multiple sclerosis	4.82e-05	0.000411	CcSEcCtD
Cisplatin—Diarrhoea—Prednisone—multiple sclerosis	4.79e-05	0.000408	CcSEcCtD
Cisplatin—Nausea—Dexamethasone—multiple sclerosis	4.77e-05	0.000407	CcSEcCtD
Cisplatin—Nausea—Betamethasone—multiple sclerosis	4.77e-05	0.000407	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—multiple sclerosis	4.62e-05	0.000394	CcSEcCtD
Cisplatin—Vomiting—Prednisone—multiple sclerosis	4.45e-05	0.000379	CcSEcCtD
Cisplatin—Rash—Prednisone—multiple sclerosis	4.41e-05	0.000376	CcSEcCtD
Cisplatin—Dermatitis—Prednisone—multiple sclerosis	4.41e-05	0.000376	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—multiple sclerosis	4.31e-05	0.000367	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—multiple sclerosis	4.2e-05	0.000358	CcSEcCtD
Cisplatin—Nausea—Prednisone—multiple sclerosis	4.16e-05	0.000354	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—multiple sclerosis	4e-05	0.000341	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—multiple sclerosis	3.72e-05	0.000317	CcSEcCtD
Cisplatin—Rash—Methotrexate—multiple sclerosis	3.69e-05	0.000314	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—multiple sclerosis	3.68e-05	0.000314	CcSEcCtD
Cisplatin—Nausea—Methotrexate—multiple sclerosis	3.47e-05	0.000296	CcSEcCtD
Cisplatin—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.01e-05	0.000357	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SRM—multiple sclerosis	2.99e-05	0.000355	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	2.97e-05	0.000353	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—STAT3—multiple sclerosis	2.97e-05	0.000353	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GPC5—multiple sclerosis	2.97e-05	0.000352	CbGpPWpGaD
Cisplatin—XDH—Metabolism—RRM1—multiple sclerosis	2.96e-05	0.000351	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.95e-05	0.00035	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	2.94e-05	0.000349	CbGpPWpGaD
Cisplatin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.93e-05	0.000348	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2RA—multiple sclerosis	2.93e-05	0.000348	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-A—multiple sclerosis	2.9e-05	0.000344	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.87e-05	0.000341	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—RRM1—multiple sclerosis	2.84e-05	0.000336	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	2.82e-05	0.000334	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—TGFB1—multiple sclerosis	2.81e-05	0.000333	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	2.76e-05	0.000327	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP27B1—multiple sclerosis	2.76e-05	0.000327	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP24A1—multiple sclerosis	2.76e-05	0.000327	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	2.72e-05	0.000323	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.71e-05	0.000322	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—MAPK1—multiple sclerosis	2.7e-05	0.00032	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SRM—multiple sclerosis	2.7e-05	0.00032	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.7e-05	0.00032	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	2.7e-05	0.00032	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SRM—multiple sclerosis	2.67e-05	0.000317	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.66e-05	0.000315	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RPL5—multiple sclerosis	2.66e-05	0.000315	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.65e-05	0.000315	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TLR4—multiple sclerosis	2.65e-05	0.000314	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DRB1—multiple sclerosis	2.65e-05	0.000314	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.62e-05	0.00031	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.6e-05	0.000308	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—STAT3—multiple sclerosis	2.59e-05	0.000308	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.59e-05	0.000307	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—ALB—multiple sclerosis	2.59e-05	0.000307	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SLC11A1—multiple sclerosis	2.54e-05	0.000302	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ICAM1—multiple sclerosis	2.54e-05	0.000301	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	2.52e-05	0.000299	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GPC5—multiple sclerosis	2.52e-05	0.000299	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—RRM1—multiple sclerosis	2.46e-05	0.000292	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD80—multiple sclerosis	2.45e-05	0.00029	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	2.43e-05	0.000288	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.42e-05	0.000287	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	2.39e-05	0.000283	CbGpPWpGaD
Cisplatin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.38e-05	0.000282	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.36e-05	0.00028	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—MAPK1—multiple sclerosis	2.36e-05	0.00028	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.31e-05	0.000274	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.3e-05	0.000272	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.29e-05	0.000271	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—BCHE—multiple sclerosis	2.29e-05	0.000271	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.23e-05	0.000264	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.16e-05	0.000256	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.16e-05	0.000256	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	2.15e-05	0.000255	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.13e-05	0.000253	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—APOE—multiple sclerosis	2.13e-05	0.000253	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP24A1—multiple sclerosis	2.11e-05	0.00025	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP27B1—multiple sclerosis	2.11e-05	0.00025	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL2—multiple sclerosis	2.1e-05	0.000249	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	2.1e-05	0.000249	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—RRM1—multiple sclerosis	2.09e-05	0.000248	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—IL6—multiple sclerosis	2.08e-05	0.000246	CbGpPWpGaD
Cisplatin—MT2A—Immune System—TYK2—multiple sclerosis	2.07e-05	0.000245	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SRM—multiple sclerosis	2.06e-05	0.000244	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD28—multiple sclerosis	2.03e-05	0.000241	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SRM—multiple sclerosis	1.98e-05	0.000235	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	1.96e-05	0.000232	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—BCHE—multiple sclerosis	1.94e-05	0.00023	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFNG—multiple sclerosis	1.93e-05	0.000229	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GPC5—multiple sclerosis	1.93e-05	0.000229	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	1.91e-05	0.000227	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.91e-05	0.000226	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	1.91e-05	0.000226	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP27B1—multiple sclerosis	1.9e-05	0.000226	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP24A1—multiple sclerosis	1.9e-05	0.000226	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—BCHE—multiple sclerosis	1.89e-05	0.000225	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.89e-05	0.000224	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	1.88e-05	0.000223	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	1.88e-05	0.000223	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.87e-05	0.000222	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—multiple sclerosis	1.87e-05	0.000222	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.86e-05	0.000221	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.84e-05	0.000219	CbGpPWpGaD
Cisplatin—CYP2B6—Biological oxidations—POMC—multiple sclerosis	1.83e-05	0.000217	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—POMC—multiple sclerosis	1.83e-05	0.000217	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—IL6—multiple sclerosis	1.81e-05	0.000215	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	1.8e-05	0.000214	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.79e-05	0.000212	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	1.76e-05	0.000208	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GPC5—multiple sclerosis	1.74e-05	0.000206	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1B—multiple sclerosis	1.73e-05	0.000205	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GPC5—multiple sclerosis	1.72e-05	0.000204	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2—multiple sclerosis	1.72e-05	0.000204	CbGpPWpGaD
Cisplatin—XDH—Metabolism—BCHE—multiple sclerosis	1.7e-05	0.000201	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ALB—multiple sclerosis	1.67e-05	0.000198	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.64e-05	0.000194	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.64e-05	0.000194	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TGFB1—multiple sclerosis	1.64e-05	0.000194	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—BCHE—multiple sclerosis	1.63e-05	0.000193	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.62e-05	0.000192	CbGpPWpGaD
Cisplatin—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.62e-05	0.000192	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—MAPK1—multiple sclerosis	1.61e-05	0.00019	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—RRM1—multiple sclerosis	1.6e-05	0.000189	CbGpPWpGaD
Cisplatin—PTGS2—Disease—GPC5—multiple sclerosis	1.58e-05	0.000188	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.58e-05	0.000187	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.49e-05	0.000177	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	1.49e-05	0.000177	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	1.49e-05	0.000176	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SRM—multiple sclerosis	1.46e-05	0.000173	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	1.46e-05	0.000173	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.45e-05	0.000172	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP24A1—multiple sclerosis	1.45e-05	0.000172	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP27B1—multiple sclerosis	1.45e-05	0.000172	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD86—multiple sclerosis	1.45e-05	0.000172	CbGpPWpGaD
Cisplatin—MT2A—Immune System—STAT3—multiple sclerosis	1.45e-05	0.000172	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—RRM1—multiple sclerosis	1.44e-05	0.000171	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—RRM1—multiple sclerosis	1.43e-05	0.000169	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.42e-05	0.000168	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	1.42e-05	0.000168	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.41e-05	0.000168	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—BCHE—multiple sclerosis	1.41e-05	0.000167	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	1.39e-05	0.000165	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	1.39e-05	0.000165	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.39e-05	0.000165	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.39e-05	0.000165	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	1.39e-05	0.000165	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000163	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SRM—multiple sclerosis	1.36e-05	0.000162	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.36e-05	0.000161	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000157	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MAPK1—multiple sclerosis	1.31e-05	0.000156	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CCR5—multiple sclerosis	1.29e-05	0.000153	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.27e-05	0.000151	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	0.000151	CbGpPWpGaD
Cisplatin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.26e-05	0.00015	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HLA-A—multiple sclerosis	1.25e-05	0.000149	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.25e-05	0.000148	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.24e-05	0.000147	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.24e-05	0.000147	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.21e-05	0.000143	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000142	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—POMC—multiple sclerosis	1.18e-05	0.00014	CbGpPWpGaD
Cisplatin—ABCC5—Disease—APOE—multiple sclerosis	1.17e-05	0.000139	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000139	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—APOE—multiple sclerosis	1.14e-05	0.000135	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	1.12e-05	0.000133	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RRM1—multiple sclerosis	1.1e-05	0.00013	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ALB—multiple sclerosis	1.08e-05	0.000128	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—MAPK1—multiple sclerosis	1.06e-05	0.000126	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.06e-05	0.000126	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD80—multiple sclerosis	1.06e-05	0.000125	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.06e-05	0.000125	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RPL5—multiple sclerosis	1.03e-05	0.000122	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.03e-05	0.000122	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.03e-05	0.000122	CbGpPWpGaD
Cisplatin—XDH—Metabolism—APOE—multiple sclerosis	1.02e-05	0.000121	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.01e-05	0.00012	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.01e-05	0.00012	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL6—multiple sclerosis	1.01e-05	0.00012	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—POMC—multiple sclerosis	1e-05	0.000119	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.92e-06	0.000118	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC11A1—multiple sclerosis	9.86e-06	0.000117	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—APOE—multiple sclerosis	9.8e-06	0.000116	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—POMC—multiple sclerosis	9.79e-06	0.000116	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.7e-06	0.000115	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	9.6e-06	0.000114	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	9.6e-06	0.000114	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.57e-06	0.000114	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	9.51e-06	0.000113	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.45e-06	0.000112	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPC5—multiple sclerosis	9.4e-06	0.000112	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.39e-06	0.000111	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—POMC—multiple sclerosis	9.2e-06	0.000109	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ALB—multiple sclerosis	9.16e-06	0.000109	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	9e-06	0.000107	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TYK2—multiple sclerosis	8.93e-06	0.000106	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ALB—multiple sclerosis	8.92e-06	0.000106	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPC5—multiple sclerosis	8.78e-06	0.000104	CbGpPWpGaD
Cisplatin—XDH—Metabolism—POMC—multiple sclerosis	8.78e-06	0.000104	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.53e-06	0.000101	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—APOE—multiple sclerosis	8.49e-06	0.000101	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—POMC—multiple sclerosis	8.42e-06	9.98e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.33e-06	9.88e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—BCHE—multiple sclerosis	8.28e-06	9.82e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.24e-06	9.77e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—BCHE—multiple sclerosis	8.19e-06	9.72e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—multiple sclerosis	8.07e-06	9.58e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ALB—multiple sclerosis	8e-06	9.49e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD28—multiple sclerosis	7.88e-06	9.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RRM1—multiple sclerosis	7.79e-06	9.24e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ALB—multiple sclerosis	7.67e-06	9.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.33e-06	8.69e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—POMC—multiple sclerosis	7.3e-06	8.65e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RRM1—multiple sclerosis	7.28e-06	8.63e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—APOE—multiple sclerosis	7.22e-06	8.57e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	7.19e-06	8.53e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	7.17e-06	8.51e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	7.03e-06	8.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.7e-06	7.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.68e-06	7.92e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ALB—multiple sclerosis	6.65e-06	7.89e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—BCHE—multiple sclerosis	6.31e-06	7.49e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—multiple sclerosis	6.25e-06	7.42e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—POMC—multiple sclerosis	6.2e-06	7.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—BCHE—multiple sclerosis	6.07e-06	7.2e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—multiple sclerosis	5.81e-06	6.89e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—multiple sclerosis	5.79e-06	6.87e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK1—multiple sclerosis	5.68e-06	6.74e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ALB—multiple sclerosis	5.66e-06	6.71e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.65e-06	6.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD86—multiple sclerosis	5.62e-06	6.67e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—APOE—multiple sclerosis	5.52e-06	6.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CCR5—multiple sclerosis	4.98e-06	5.91e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—APOE—multiple sclerosis	4.98e-06	5.91e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—APOE—multiple sclerosis	4.93e-06	5.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—multiple sclerosis	4.86e-06	5.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.85e-06	5.75e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—POMC—multiple sclerosis	4.74e-06	5.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APOE—multiple sclerosis	4.53e-06	5.38e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.5e-06	5.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BCHE—multiple sclerosis	4.48e-06	5.31e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.42e-06	5.25e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—IL6—multiple sclerosis	4.37e-06	5.18e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ALB—multiple sclerosis	4.32e-06	5.13e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—POMC—multiple sclerosis	4.28e-06	5.07e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—POMC—multiple sclerosis	4.23e-06	5.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BCHE—multiple sclerosis	4.18e-06	4.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD80—multiple sclerosis	4.1e-06	4.86e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ALB—multiple sclerosis	3.9e-06	4.63e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ALB—multiple sclerosis	3.86e-06	4.58e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—APOE—multiple sclerosis	3.8e-06	4.5e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—APOE—multiple sclerosis	3.65e-06	4.33e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TYK2—multiple sclerosis	3.46e-06	4.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—POMC—multiple sclerosis	3.26e-06	3.87e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—POMC—multiple sclerosis	3.14e-06	3.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—multiple sclerosis	3.13e-06	3.71e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ALB—multiple sclerosis	2.97e-06	3.53e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ALB—multiple sclerosis	2.86e-06	3.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—APOE—multiple sclerosis	2.69e-06	3.19e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APOE—multiple sclerosis	2.52e-06	2.98e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—multiple sclerosis	2.42e-06	2.87e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—POMC—multiple sclerosis	2.31e-06	2.74e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—multiple sclerosis	2.25e-06	2.67e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—multiple sclerosis	2.25e-06	2.66e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK1—multiple sclerosis	2.2e-06	2.61e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—POMC—multiple sclerosis	2.16e-06	2.56e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALB—multiple sclerosis	2.11e-06	2.5e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALB—multiple sclerosis	1.97e-06	2.34e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—IL6—multiple sclerosis	1.69e-06	2.01e-05	CbGpPWpGaD
